University of Patras
Η μοριακή μελέτη της διακίνησης του μεταφορέα γλυκόζης GLUT4 στα λιποκύτταρα ατόμων με νοσογόνο παχυσαρκία
Abstract
dc:descriptionIntroduction: Obesity constitute a worldwide epidemic and is often, accompanied by Insulin Restistance (IR), Metabolic Syndrome (MS), Diabetes Mellitus type II (DM II) and increased incidence of cardiometabolic disease, especially in the mobidly obese people (BMI ≥ 40). In adult obesity, adipose tissue (AT) undergo pathologic remodeling, which is characterized by hypertrophy, inflammation, altered secretion of adipokines, hormones produced by AT (for example low adiponectin secretion) and development of local and subsequent systematic IR. Adipocytes of morbidly obese with Insulin Resistance, usualy demonstrate disfunction of the intracellular pathway of insulin and adiponectin. The main pathophysiologic event is the disturbance of glucose transporter, GLUT4 trafficking to the plasma membrane (PM). Normally, insulin activates its receptor with sequential activation of the molecules: Insulin Receptor Substrate 1 (IRS1), Phosphatidylinositol 3 Kinase (PI3K) and Protein Kinase B, ΡΚΒ/Akt ΙΙ. Furthermore, adiponectin’s autocrine function in AT begins with the interaction with its receptor, AdipoR1, which in turn activates APPL1 (Adaptor protein of adiponectin’s receptor). The result of both pathways is the GLUT4 translocation to PM, to facilitate glucose influx. Rab5 GTPase, activated by Gapex5, plays a crucial role in both the aforementioned pathways. Another molecule, related to the development of IR, is aquaglyceroporin 7 (AQP7), which mediates the efflux of lipolysis-derived glycerol to the circulation. Aim: To investigate the intracellular mechanisms of glucose and glycerol trafficking, by GLUT4 and AQP7, respectively and the possible involvement of the transduction pathways of insulin (p85 subunit of ΡΙ3Κ, Akt ΙΙ, Rab5 and Gapex5) and adiponectin (AdipoR1 and APPL1), of mature adipocytes, in the pathophysiology of morbid obesity, insulin resistance and diabetes mellitus type II, comorbidities of some obese people. Materials and methods: For this purpose, primary cultures of mature adipocytes were developed from surgery obtained biopsies from visceral (Visc), abdominal subcutaneous (Sub) and gluteal subcutaneous (Glut) fat depot, from 20 lean (BMI≤ 25 Kg/m2) and 36 morbidly obese (BMI>40 Kg/m2). Morbidly obese divided into two groups based on the existence of DM II, with (MODM) or without DM II (MOW). The relative mRNA and protein expression (PE) of GLUT4, ΡΙ3Κ p85, Akt ΙΙ, Rab5, Gapex5, adiponectin, AdipoR1, APPL1 and AQP7, were relatively quantified with RT-PCR (Reverse Transcriptase Polymerase Chain Reaction) and Western Immunoblotting, respectively. Full biochemical studies performed in blood samples. Serum Insulin, High Molecular Weight (HMW) adiponectin and glycerol measured using ELISA, whereas insulin resistance index, HOMA-IR calculated. Results: Regarding serum measurments, glycerol was elevated, while HMW adiponectin found reduced in MOW and MODM, compared to the lean. The study of the expression of the insulin pathway’s molecules, revealed that: 1) GLUT4 protein significantly decreased in Visc and Sub of obese, MOW and MODM and in Glut of obese and MODM, compared to the lean and 2) Akt II mRNA reduced in Sub of obese, MOW and MODM, in comparison to the lean. During Western Immunoblotting two bands of Akt II, identified, at 60 and 65kDa and named as Akt II and pAkt II, respectively. 3) pAkt II (representing the basically phosphorylated isoform of Akt) was decreased in Sub of MOW, compared to MODM, while Akt II protein expression was reduced in Sub of MOW, in comparison to the lean. Furthermore, 4) PI3K p85 mRNA of Glut in obese was induced, compared to the other fat depots and in MOW and MODM was elevated, compared to Visc, while PI3K p85 mRNA in Visc of obese and especially of MODM was positively correlated with serum insulin and HOMA-IR. 5) PI3K p85 protein found statistical significantly increased in Sub of MODM, compared to the lean and to MOW. 6) Rab5 mRNA was decreased in Visc of lean, compared to Glut, while 7) Rab5 protein was induced in obese and MODM in Glut, compared to Sub and Rab5 protein in Sub of obese, MOW and MODM was reduced, compared to the lean, and 8) MODM had increased protein expression of Gapex5 in Sub, compared to MOW. Regarding the adiponectin pathway, our results showed that: 1) the intracellular relative concentration of adiponectin increased in Sub and Glut of obese compared to the lean. 2) AdipoR1 mRNA induced in Visc and Glut of obese, and both groups, compared to the lean and increased in Glut of MODM compared to Sub and 3) AdipoR1 protein increased in Glut of obese and MODM, compared to the lean and to the Visc depot. 4) APPL1 mRNA found reduced in Visc and Glut of MODM compared to MOW, while especially in Glut of MODM was reduced, in comparison to the lean. 5) APPL1 protein was found decreased in Visc of obese and MOW and in Sub of obese and MODM, compared to the lean, while MODM in Glut had reduced APPL1 protein, when compared to MOW. The study of aquaglyceroporin 7 protein revealed a new isoform of observed molecular weight of 37kDa. Although, 41kDa isoform appeared with no statistical differences, 37 and 34kDa isoforms of AQP7 significantly decreased in Visc and in Sub of obese and their groups, compared to the lean. Especially 34kDa isoform of AQP7 showed reduced expression in Sub of MODM, compared to MOW. Conclusions: MODM have developed full-advanced dysfunction of the insulin signaling pathway, due to the reduced protein expression of GLUT4 in all three fat depots, since previously reported that low GLUT4 expression, alone, in adipose tissue is capable of disruption of whole body glucose homeostasis. In gluteal subcutaneous AT, PE of GLUT4 of MOW, APPL1 of obese and especially of MOW, pAkt II/Akt II and 37 and 34kDa isoforms of AQP7 of MOW and MODM, was preserved at similar levels as in their respective lean. Alongside the mRNA expression of PI3K p85 of MOW and MODM and of Rab5 mRNA of lean were found increased in Glut, compared to Visc, while Rab5 protein in Glut of obese and MODM was induced in Glut, when compared to Sub. Obese and specifically MODM exhibit increased expression of AdipoR1 in Glut, compared to the lean and to the other fat depots. All the above possibly indicate the effort of gluteal subcutaneous tissue, as a more metabolic active depot of AT, to reinforce insulin sensitivity, through the insulin and adiponectin signaling pathways, which is effective for MOW, but not for systemic insulin resistant MODM. In Sub, MOW as much as MODM had reduced protein expression of Rab5, compared to the lean, while MODM showed increased Gapex5 and pAkt II, compared to MOW. The enhancement of Gapex5, as a Rab5 activator and of pAkt II, the only isoform of Akt that can be activated by insulin, possibly reflect a compensating mechanism for the reinforcement of insulin pathway in adipocytes of MODM, the most metabolically compromised group. Furthermore, p85 subunit of PI3K represents another regulator of Rab5, due to the fact that insulin mediated activation of PI3K p85 allows the translocation of Rab5 to the PM, in order to activate the catalytic action of PI3K and subsequently Akt II. Afterwards, PI3K p85 deactivates Rab5. The PI3K/Akt pathway enhances lipogenesis, which dominates over lipolysis in the hypertrophic adipocytes of obesity and especially PI3K p85 positively correlates to IR and DM II. In our results in Sub of MODM, PE of PI3K p85 found increased, compared to the lean and MOW, while Rab5 and GLUT4 decreased, compared to the lean. PI3K p85 mRNA of obese and specifically MODM was positively correlated to serum insulin and HOMA-IR index. Therefore, in Sub AT of MODM, the overexpression of p85 subunit of PI3K is possibly the cause of insulin pathway dysfunction, reflected by the low GLUT4 expression, suppressing Rab5 expression. As a result, PI3K overexpression, enhances or causes Insulin Resistance of abdominal subcutaneous adipose tissue and further mediates the lipid accumulation in the already, hypertrophic adipocytes and ultimately contributes to the pathologic expansion of Sub and finaly the development of whole body IR of MODM. Regarding the study of the adiponectin pathway, decreased concentration of serum HMW adiponectin at obese and their groups was found, in accordance with previous studies. Furthermore, APPL1 protein was decreased in Visc of obese and MOW, and in Sub of obese and MODM, compared to the lean. In Glut MODM reduced APPL1 mRNA and protein, compared to the MOW, while MOW displayed similar levels with their respective lean. In contrast, the PE of AdipoR1 was unaltered in Visc and Sub and only in Glut of MODM was increased, compared to the lean. Consequently, the adiponectin pathway dysfunction, characterized by reduced APPL1. In fact, the downregulation of APPL1 seems to be the cause of the metabolic disturbance of these tissues and the impaired glucose homeostasis of adipocytes in obesity, as it is reflected by the downregulation of GLUT4 in all fat depots and with greater effect on MODM. In respect of aquaglyceroporin 7, which is responsible for glycerol efflux, there were previously found two isoforms of 41 and 34kDa molecular weight, but it is the first description of another isoform of molecular weight of 37kDa. Meanwhile 37 and 34kDa isoforms of AQP7 were decreased in Visc and Sub of obese and both their groups, it was also observed an increase of serum glycerol in obese. A possible explanation involves the enhancement of AQP7 of myocytes. Furthermore, 34kDa isoform of AQP7 reduced in Sub of MODM, compared to MOW, thus possibly constitutes an indicator of insulin sensitivity in morbidly obese. On the other hand, the expression of 41kDa isoform showed no differences between lean and obese. It has proposed that AQP7 isoforms represent products of post-translational processing of a type of glycosylation, different to N-linked, probably O-glycosylation. Enhancement of O-glycosylation has related to glucotoxicity, IR and DM II, since the processing inhibits insulin signaling. We suggest that enhancement of GlcNAc transferase, the enzyme responsible for O-glycosylation, mediates the production of the more glycosylated, 41 and 37kDa isoforms of AQP7, possibly the more active ones. As a result, enhancement of GlcNAc transferase may participate in an effort to compensate the adipocyte dysfunction in obesity, characterized by reduced basal lipolysis and glucose homeostasis disruption, with maintenance of glycerol efflux, in order to avoid hypertrophy. Caveolae are microdomains inside the cholesterol enriched lipid rafts. Caveolae are involved in the initiation of PI3K/Akt branch of the insulin signaling pathway and provide the necessary modulation of PM for the fusion with the GLUT4-containing vesicles. In obesity the decrease of cholesterol at caveolae leads to inhibition of insulin signaling, downregulation of GLUT4 and hypertrophy of the adipocytes, which also exhibit reduced basal and catecholamine-induced lipolysis. According to the aforementioned results, in morbid obesity the downregulation of the protein expression of 37 and 34kDa isoforms of AQP7 possibly reflects the decreased lipolysis of the hypertrophic adipocytes, which on top of that exhibit reduced cholesterol at the caveolae of plasma membrane. In obesity, the triglycerides accumulation inside the lipid droplet aggravates the preexisting hypertrophy and results the impairment of insulin signaling, as it is prooved by the decreased GLUT4 expression in all fat depots, regardless of the existence of DM II and may lead to the development of whole body insulin resistance and increased risk of Diabetes Mellitus type II.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mourelatou, Roza
- Μουρελάτου, Ρόζα
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/47228